Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Wildlife Diseases|October 1, 1980
Demodicosis in African Buffalo (Syncerus caffer caffer) in BotswanaN Dräger, G D PaineCancer Chemotherapy and Pharmacology|November 7, 1999
Wortmannin inhibits the growth of mammary tumors despite the existence of a novel wortmannin-insensitive phosphatidylinositol-3-kinaseL E Lemke, G D Paine-Murrieta, C W Taylor, et al.Seminars in Oncology|August 1, 1996
Effects of amifostine and paclitaxel on growth of human ovarian carcinoma xenografts in the severe combined immune-deficient mouse: preliminary resultsG D Paine, C W Taylor, M H Lopez, et al.Anticancer Research|March 12, 1998
Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agentsL Engman, I Cotgreave, M Angulo, et al.Neoplasia (New York, N.Y.)|August 10, 2000
Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imagingJ P Galons, M I Altbach, G D Paine-Murrieta, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agentsR Bagatell, G D Paine-Murrieta, C W Taylor, et al.European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintainedC W Taylor, L M Wang, A F List, et al.Cancer Research|December 15, 1996
Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cellsA Gallegos, J R Gasdaska, C W Taylor, et al.Cancer Chemotherapy and Pharmacology|January 1, 1997
Human tumor models in the severe combined immune deficient (scid) mouseG D Paine-Murrieta, C W Taylor, R A Curtis, et al.Pageof 1